Vision Scs F2, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 573,404 shares at $11.23 ($5.6M) on 2022-05-16, disclosed to the SEC on 2022-05-16.
Open-market sale of $5.6M CGEM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.25 | 264,072 | $2.4M | 43.2% |
| 2 | $9.96 | 85,319 | $850K | 15.0% |
| 3 | $9.96 | 85,319 | $850K | 15.0% |
| 4 | $10.48 | 34,189 | $358K | 6.3% |
| 5 | $10.48 | 34,189 | $358K | 6.3% |
| 6 | $11.23 | 35,158 |
| $395K |
| 7.0% |
| 7 | $11.23 | 35,158 | $395K | 7.0% |
| Total | $9.85 avg | 573,404 | $5.6M | 100% |